PKM and non-small cell lung carcinoma: Further, targeting PKM2 with SMI resulted in a concentration-dependent decrease in NSCLC cell viability where the IC50 of SMI (concentration of SMI causing 50% inhibition of NSCLC cell line growth) ranged between 30–65 μM (Fig 3A).